+ Watch THLD
on My Watchlist
A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.
Looking for a bounce into ASCO. We are past yet another round of dilution and there has been some notable insider and institutional buying of late. Highly speculative but not much more then some of my other holdings. M21 in at 1.87...boo yah
took awhile but boo YAH!http://www.reuters.com/finance/stocks/THLD.O/key-developments
sometimes you just got to let it run... : )
Porte: yeay is right...DSCO is next on tap...and that is where the real chips are placed! : ) THLD @ 6.34 ... DSCO now @ 2.82
Porte: next up DSCO?
this stock makes me smile... : ) This was one of the most random of my picks and at the time I had thought my timing was terrible. It was a small initial position that is now one of my largest dollar gainers. From here I like DSCO, SNSS and HGSI to follow suit in the short term. : )What are your top 3 Portefeuille? I know DSCO is #1 of course
I bought back a bunch of shares at $5.97 (doubled the existing position) after the fallout from the weekend (ESMO). Nate Sadeghi and Adam F are bearish...so I upped my bullishness. : )
fund's top3 single company positions are ALGETA:NO, MOR:GY and ROG:VX currently. Including IBB and BB Biotech (BION:SW) holdings the fund's top4 positions are probably ALGETA:NO, CELG, GILD and VRTX. That depends on current holdings of BB Biotech -> http://www.bbbiotech.ch/en/bb-biotech/strategy-portfolio/portfolio-overview/entire-portfolio/
Maybe Actelion makes the top4, I just hope they have scaled back that position since the end of June. I keep adjusting the BION:SW position size a little depending on the discount to NAV, see http://www.bloomberg.com/quote/BION:SW and http://www.bbbiotech.ch/en/bb-biotech/investor-relations/share-price/ I hope Vontobel makes another offer to acquire them in the not so distant future -> http://www.bloomberg.com/news/2012-07-22/vontobel-won-t-abandon-bb-biotech-bid-sonntagszeitung-reports.html.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions